Strategies for clinical trials in type 1 diabetes
نویسندگان
چکیده
منابع مشابه
Immunotherapy for Type 1 Diabetes – Preclinical and Clinical Trials
According to the American Diabetes Association (http://www.diabetes.org/diabetesbasics/diabetes-statistics), 2-3 million individuals in the United States have type 1 diabetes and about 1 in every 400 to 600 children and adolescents was affected by the disease in 2007. Similar to other autoimmune diseases, allergies, and asthma, the incidence of type 1 diabetes is on the increase at an alarming ...
متن کاملEffectiveness of Support Resources for Patients with Type 2 Diabetes: A Systematic Review of Clinical Trials in Iran
Introduction and Objectives: Type 2 diabetes is a common metabolic disorder worldwide. Health policymakers face challenges in the management of this chronic disease. According to previous studies, due to the complex nature of diabetes, the use of support resources can be effective in improving disease management. The current study aimed to identify the sources of support for patients with type ...
متن کاملInnovative immunological strategies for type 1 diabetes.
La gran dificultad para el desarrollo de estrategias preventivas o terapéuticas para la diabetes mellitus tipo 1 (DT1) es su etiología aún desconocida. La administración de insulina exógena es el tratamiento sustitutivo estándar, pero a pesar de los avances en este campo, para la mayoría de los pacientes sigue siendo complicado alcanzar un buen control de la glucemia. Como enfermedad autoinmune...
متن کاملFuture intervention trials in type 1 diabetes.
The recently completed trials using insulin (U.S.) and nicotinamide (Europe) were not effective in preventing type 1 diabetes (1,2), but they leave an important legacy of goodwill among their collaborators and expertise in the conduct of such trials and a network through which more may be carried out. A commentary on the trials has recently been published (3), and its authors urge “a different ...
متن کاملBiomarkers for immune intervention trials in type 1 diabetes.
After many efforts to improve and standardize assays for detecting immune biomarkers in type 1 diabetes (T1D), methods to identify and monitor such correlates of insulitis are coming of age. The ultimate goal is to use these correlates to predict disease progression before onset and regression following therapeutic intervention, which would allow performing smaller and shorter pilot clinical tr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Autoimmunity
سال: 2016
ISSN: 0896-8411
DOI: 10.1016/j.jaut.2016.03.008